NewsSource: EClinCloud official website archive

Registration Countdown! EClinCloud Japan eCOA Webinar Launching Soon

1 min readEClinCloud Editorial Team
Archived article cover: Registration countdown — EClinCloud eCOA Japan webinar launching soon

中日临床研究AI与eCOA线上研讨会海报  

 

EClinCloud cordially invites you to our upcoming Japan webinar. Taking a cross-border perspective, this webinar will explore the application of AI technology in eCOA, share our practical experience from the China market, and feature Japanese industry experts offering forward-looking insights to jointly explore how AI can support innovative development in eCOA.

 

 Webinar Topic:

How AI is Transforming eCOA

Insights from China, Strategies for Japan

 

Time:

July 28, 2025, 15:00-16:00 (Beijing Time)

 

Registration link :

https://peatix.com/event/4483542/  

 

 

What you will gain from this seminar :

●  How AI is applied to eCOA to improve patient compliance and data quality

● Real-world case experience from EClinCloud's practice in China

● Leading-edge insights and strategic perspectives from Japanese clinical trial experts

 

This webinar will offer cross-border perspectives and practical implementation experience to help you better track innovation trends and improve study efficiency. We invite industry colleagues to register and join us in exploring the future direction of AI-enabled eCOA. We look forward to seeing you online!

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.